CA2816207C - Formules comprenant des elements tres solubles et une vitamine pour la prevention et l'amelioration de l'osteoporose - Google Patents

Formules comprenant des elements tres solubles et une vitamine pour la prevention et l'amelioration de l'osteoporose Download PDF

Info

Publication number
CA2816207C
CA2816207C CA2816207A CA2816207A CA2816207C CA 2816207 C CA2816207 C CA 2816207C CA 2816207 A CA2816207 A CA 2816207A CA 2816207 A CA2816207 A CA 2816207A CA 2816207 C CA2816207 C CA 2816207C
Authority
CA
Canada
Prior art keywords
calcium
magnesium
zinc
acetate
solubility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2816207A
Other languages
English (en)
Other versions
CA2816207A1 (fr
Inventor
Yun Kau Tam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinoveda Canada Inc
Original Assignee
Sinoveda Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TW100126601A external-priority patent/TWI516279B/zh
Application filed by Sinoveda Canada Inc filed Critical Sinoveda Canada Inc
Publication of CA2816207A1 publication Critical patent/CA2816207A1/fr
Application granted granted Critical
Publication of CA2816207C publication Critical patent/CA2816207C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4875Compounds of unknown constitution, e.g. material from plants or animals
CA2816207A 2011-07-27 2012-07-27 Formules comprenant des elements tres solubles et une vitamine pour la prevention et l'amelioration de l'osteoporose Expired - Fee Related CA2816207C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
TW100126601A TWI516279B (zh) 2010-07-28 2011-07-27 預防和改善骨質疏鬆症之含有高可溶性元素及維生素的調配物
TW100126601 2011-07-27
US201161512685P 2011-07-28 2011-07-28
US61/512,685 2011-07-28
PCT/IB2012/053872 WO2013014654A2 (fr) 2011-07-27 2012-07-27 Formules comprenant des éléments très solubles et une vitamine pour la prévention et l'amélioration de l'ostéoporose

Publications (2)

Publication Number Publication Date
CA2816207A1 CA2816207A1 (fr) 2013-01-31
CA2816207C true CA2816207C (fr) 2014-11-18

Family

ID=47602056

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2816207A Expired - Fee Related CA2816207C (fr) 2011-07-27 2012-07-27 Formules comprenant des elements tres solubles et une vitamine pour la prevention et l'amelioration de l'osteoporose

Country Status (6)

Country Link
EP (1) EP2736518A2 (fr)
KR (1) KR20140054124A (fr)
AU (1) AU2012288401B9 (fr)
BR (1) BR112014001728A2 (fr)
CA (1) CA2816207C (fr)
WO (1) WO2013014654A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095798A2 (fr) 2008-01-28 2009-08-06 Beauty Pearl Group Limited Formules comprenant du calcium, du magnésium, du zinc et de la vitamine d3 pour la prévention et l'amélioration de l'ostéoporose
WO2015166468A1 (fr) * 2014-05-02 2015-11-05 Sinoveda Canada, Inc. Formules comprenant des éléments très solubles et de la vitamine d pour la prévention et le traitement de troubles intestinaux pendant une supplémentation en calcium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095798A2 (fr) * 2008-01-28 2009-08-06 Beauty Pearl Group Limited Formules comprenant du calcium, du magnésium, du zinc et de la vitamine d3 pour la prévention et l'amélioration de l'ostéoporose

Also Published As

Publication number Publication date
AU2012288401B9 (en) 2015-01-29
WO2013014654A2 (fr) 2013-01-31
BR112014001728A2 (pt) 2017-02-21
AU2012288401A1 (en) 2013-05-02
AU2012288401B2 (en) 2013-08-01
EP2736518A2 (fr) 2014-06-04
CA2816207A1 (fr) 2013-01-31
KR20140054124A (ko) 2014-05-08
WO2013014654A3 (fr) 2013-03-21
WO2013014654A4 (fr) 2013-06-06

Similar Documents

Publication Publication Date Title
US20140154332A1 (en) Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
US20140017312A1 (en) Multi-vitamin and Mineral Nutritional Supplements
JPH05505935A (ja) ビタミン,ミネラルおよび他の有利な補給剤の徐放性処方
AU2011336145B2 (en) Galenic composition suitable for administration to a non-human animal, uses thereof, and associated methods
JP2008523112A (ja) 体重の減少を促進するための栄養補助組成物
WO2010008976A2 (fr) Compléments combinés de calcium, magnésium et vitamine d
CN101181289A (zh) 一种13种复合维生素注射剂及其生产工艺
CA2816207C (fr) Formules comprenant des elements tres solubles et une vitamine pour la prevention et l'amelioration de l'osteoporose
CN109090319A (zh) 乳矿物盐压片糖果
WO2015001329A1 (fr) Comprimé à mâcher
WO2007046123A2 (fr) Composition contenant les vitamines k et d destinee a prevenir et a traiter l'osteoporose
JP2014523921A (ja) 骨粗鬆症の予防および回復のための高溶解性成分とビタミンを含む製剤
KR20140017979A (ko) 중장년층용 비타 하이브리드 정제 및 그 제조 방법
CN110122862A (zh) 一种降低血糖的特殊医学用途食品及其制备方法
Fujita Intestinal absorption of calcium
WO2013114390A1 (fr) Système d'administration de médicament à rétention gastrique de compléments de calcium

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130515

MKLA Lapsed

Effective date: 20170727